标题
Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus
作者
关键词
-
出版物
INFLAMMOPHARMACOLOGY
Volume 29, Issue 6, Pages 1625-1639
出版商
Springer Science and Business Media LLC
发表日期
2021-10-21
DOI
10.1007/s10787-021-00879-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
- (2021) Manuel Grundmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HWL‐088, a new potent free fatty acid receptor 1 (FFAR1) agonist, improves glucolipid metabolism and acts additively with metformin in ob/ob diabetic mice
- (2020) Yueming Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Design and Identification of a GPR40 Full Agonist (SCO-267) Possessing a 2-Carbamoylphenyl Piperidine Moiety
- (2020) Hideki Furukawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity
- (2019) Hikaru Ueno et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold
- (2019) Zheng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review
- (2019) Zheng Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status
- (2018) Chinedum Eleazu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- GPR40-Mediated Gα12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets
- (2018) Marie-Laure Rives et al. MOLECULAR PHARMACOLOGY
- Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial
- (2018) Venu Menon et al. DIABETES CARE
- Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
- (2018) Hui Huang et al. ACS Medicinal Chemistry Letters
- Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
- (2017) Zheng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode
- (2017) Elizabeth A. Jurica et al. JOURNAL OF MEDICINAL CHEMISTRY
- Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges
- (2017) Zheng Li et al. MEDICINAL RESEARCH REVIEWS
- The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
- (2016) Chafiq Hamdouchi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models
- (2015) Dan-yang Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558
- (2015) Rieko Takano et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit
- (2015) A. D. Mancini et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
- (2015) K. Kaku et al. DIABETES OBESITY & METABOLISM
- β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1
- (2015) Arturo D. Mancini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of fatty acids in insulin resistance
- (2015) Barry Sears et al. Lipids in Health and Disease
- Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
- (2015) Cong Tang et al. NATURE MEDICINE
- GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
- (2015) Maria Hauge et al. Molecular Metabolism
- Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus
- (2014) Elisabeth Defossa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The importance of synthetic drugs for type 2 diabetes drug discovery
- (2013) Maliheh Safavi et al. Expert Opinion on Drug Discovery
- Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion
- (2013) Hirotsugu Tanaka et al. LIFE SCIENCES
- Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1
- (2013) Yumei Xiong et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Differences in Gene Expression and Cytokine Release Profiles Highlight the Heterogeneity of Distinct Subsets of Adipose Tissue-Derived Stem Cells in the Subcutaneous and Visceral Adipose Tissue in Humans
- (2013) Sebastio Perrini et al. PLoS One
- A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
- (2013) Chiori Yabuki et al. PLoS One
- The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
- (2013) Arturo D. Mancini et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Free Fatty Acid Receptor 1: A New Drug Target for Type 2 Diabetes?
- (2012) Mourad Ferdaoussi et al. Canadian Journal of Diabetes
- TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
- (2012) Charles F Burant et al. LANCET
- Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas-duodenum homeobox-1
- (2012) M. Kebede et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G Protein–Coupled Receptor Deorphanizations
- (2011) Olivier Civelli et al. Annual Review of Pharmacology and Toxicology
- AMG 837: A potent, orally bioavailable GPR40 agonist
- (2011) Jonathan B. Houze et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system
- (2011) Kazuo Nakamoto et al. BRAIN RESEARCH
- GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes
- (2011) T. Araki et al. DIABETES OBESITY & METABOLISM
- Acute stimulation of glucagon secretion by linoleic acid results from GPR40 activation and [Ca2+]i increase in pancreatic islet α-cells
- (2011) Li Wang et al. JOURNAL OF ENDOCRINOLOGY
- Free Fatty Acid Receptors FFAR1 and GPR120 as Novel Therapeutic Targets for Metabolic Disorders
- (2011) Takafumi Hara et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
- (2010) Da Young Oh et al. CELL
- Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass
- (2010) G. Fontés et al. DIABETOLOGIA
- Lipophilicity in drug discovery
- (2010) Michael J Waring Expert Opinion on Drug Discovery
- The G-Protein−Coupled Receptor GPR40 Directly Mediates Long-Chain Fatty Acid−Induced Secretion of Cholecystokinin
- (2010) Alice P. Liou et al. GASTROENTEROLOGY
- Taste Preference for Fatty Acids Is Mediated by GPR40 and GPR120
- (2010) C. Cartoni et al. JOURNAL OF NEUROSCIENCE
- Review: Free fatty acid receptors: emerging targets for treatment of diabetes and its complications
- (2010) R. Lee Kennedy et al. Therapeutic Advances in Endocrinology and Metabolism
- Overexpression of GPR40 in Pancreatic -Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice
- (2009) K. Nagasumi et al. DIABETES
- From chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation
- (2009) L. Lionetti et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids
- (2009) S. Del Guerra et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- On high-frequency insulin oscillations
- (2008) Ole Schmitz et al. AGEING RESEARCH REVIEWS
- The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering
- (2008) Rachel P. Wildman ARCHIVES OF INTERNAL MEDICINE
- The Fatty Acid Receptor GPR40 Plays a Role in Insulin Secretion In Vivo After High-Fat Feeding
- (2008) M. Kebede et al. DIABETES
- Lack of FFAR1/GPR40 Does Not Protect Mice From High-Fat Diet-Induced Metabolic Disease
- (2008) H. Lan et al. DIABETES
- Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
- (2008) S. Edfalk et al. DIABETES
- Modulation of Osteoclastogenesis by Fatty Acids
- (2008) Jillian Cornish et al. ENDOCRINOLOGY
- Diazoxide-induced β-cell rest reduces endoplasmic reticulum stress in lipotoxic β-cells
- (2008) Ernest Sargsyan et al. JOURNAL OF ENDOCRINOLOGY
- Structural diversity of G protein-coupled receptors and significance for drug discovery
- (2008) Malin C. Lagerström et al. NATURE REVIEWS DRUG DISCOVERY
- International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions
- (2008) L. A. Stoddart et al. PHARMACOLOGICAL REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now